本页面由Tiger Trade Technology Pte. Ltd.提供服务

LifeStance Health Group, Inc.

12.48
+0.06000.48%
盘后:12.480.00000.00%16:04 EDT
成交量:219.29万
成交额:2,734.14万
市值:47.68亿
市盈率:96.87
高:12.54
开:12.45
低:12.38
收:12.42
52周最高:13.56
52周最低:4.77
股本:3.82亿
流通股本:2.76亿
量比:0.81
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):0.1288
每股收益(LYR):0.0200
净资产收益率:3.43%
总资产收益率:2.32%
市净率:3.23
市盈率(LYR):624.00

数据加载中...

2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

重要事件披露

Form 8-K - Current report
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities